Table 3.
Effect of anti-TNF in patients in the highest E/e’ quartile (E/e’ > 9).
| E/e’ > 9 (n) | Baseline | Follow-Up | p-Value |
|---|---|---|---|
| E/A (6) | 1.0 (±0.4) | 1.0 (±0.3) | 0.97 |
| E/e’ (7) | 11.8 (±3.0) | 10.9 (±4.2) | 0.34 |
| deceleration time, sec (4) | 0.23 (±0.06) | 0.26 (±0.05) | 0.34 |
| ejection fraction (4) | 62.0 (±7.4) | 62.2 (±9.5) | 0.97 |
| LV mass index, gram/m2 (5) | 83.0 (±26.1) | 100.6 (54.1) | 0.28 |
| LA volume index, mL/m2 (4) | 36.6 (±3.8) | 36.6 (±3.8) | 0.87 |
| GLS (6) | −18.0 (±3.5) | −18.2 (±2.7) | 0.90 |
Values are displayed as mean ± standard deviation (SD) or median (IQR). LA = left atrial, LV = left ventricular, GLS = global longitudinal strain.